In 46% of U.S. counties, there are no retail pharmacies within 10 miles, according to a study from The Ohio State University. 

Ann Arbor-based Michigan Medicine is bolstering staff at five of its outpatient pharmacies as Rite Aid closes all its stores in the state, according to an Aug. 25 report from MLive. 

The FDA is investigating allegations of misconduct in Lykos Therapeutics' studies of its experimental MDMA drug, which failed to win agency approval in early August, according to The Wall Street Journal. 

Johnson & Johnson plans to end upfront discounts for two drugs sold to disproportionate share hospitals under the 340B program, replacing them with a rebate application process, The Wall Street Journal reported Aug. 23.

MetroHealth has increased patients' refill retention rate from 35% to 80% — thanks to a few shifts in its operating model.

The FDA signed off on updated mRNA COVID-19 vaccines from Pfizer and Moderna. The new shots target the KP.2 strain and are expected to be available at pharmacies, hospitals and clinics within a few days, the drugmakers said. 

Staffing and scheduling issues contributed to the highest number of negative experiences reported by pharmacy professionals, according to the latest Pharmacy Workplace and Well-being Reporting released by the American Pharmacists Association. 

Since the 2012-13 school year, pharmacy schools have seen fewer applicants for PharmD programs. 

A fire broke out Aug. 21 at a facility that makes and exports active pharmaceutical ingredients for the U.S. and other countries. There were 17 deaths and 33 injuries from the blaze, according to an Aug. 22 report from The Times of India. 

Ridgewood, N.J.-based Valley Health System has opened the system's first compounding pharmacy. 

In a phase 3 trial spanning three years, weekly injections of tirzepatide reduced the risk of Type 2 diabetes by 94%, Eli Lilly said Aug. 20. 

The Board of Pharmacy Specialties is developing an exam for a new specialty pharmacy certification. 

Premier recently recognized six U.S. hospitals and health system pharmacies and one pharmacist through the company's 2024 Premier Pharmacy awards. 

Johnson & Johnson's oncology treatment regimen, Rybrevant (amivantamab-vmjw) and Lazcluze (lazertinib), is now approved as a first-line therapy, the drugmaker said Aug. 20. 

A context-aware ChatGPT might be of use in pharmacies, according to a recent study.

Northern Maine Medical Center in Fort Kent is moving its outpatient pharmacy services to St. John Valley Pharmacy, an independently owned pharmacy in the area.

An alternative option to appendectomies is becoming more mainstream, The Washington Post reported Aug. 17. 

Gabapentin is FDA-approved for epileptic seizures and postherpetic neuralgia, which is lasting pain after a shingles infection. Its off-label uses are climbing as physicians discover new applications, The New York Times reported Aug. 17. 

Denmark-based Bavarian Nordic said Aug. 17 it plans to ramp up mpox vaccine manufacturing. 

Anecdotally, some physicians are getting more comfortable prescribing compounded versions of popular weight loss drugs Wegovy and Zepound, which are both in short supply, NBC News reported Aug. 16.